|
Aug-13-26 08:38AM
|
PDS Biotechnology: Q2 Earnings Snapshot
|
link
|
(Associated Press)
|
|
Aug-13-26 08:30AM
|
PDS Biotech Reports Second Quarter 2026 Financial Results
|
link
|
(GlobeNewswire)
|
|
Aug-11-26 08:25AM
|
PDS Biotech Announces Strategic Refocus Prioritizing PDS0301 in Metastatic Colorectal Cancer (mCRC) and Partnership Strategy for PDS0101
|
link
|
(GlobeNewswire)
|
|
May-13-26 07:02PM
|
PDS Biotechnology Corp (PDSB) Q1 2026 Earnings Call Highlights: Strategic Advancements and ...
|
link
|
(GuruFocus.com)
|
|
May-13-26 12:52PM
|
PDS Biotechnology Corporation Q1 2026 Earnings Call Summary
|
link
|
(Moby)
|
|
May-13-26 07:10AM
|
PDS Biotechnology: Q1 Earnings Snapshot
|
link
|
(Associated Press)
|
|
May-13-26 07:00AM
|
PDS Biotech Reports First Quarter 2026 Financial Results and Provides Clinical Programs and Corporate Update
|
link
|
(GlobeNewswire)
|
|
May-06-26 08:00AM
|
PDS Biotech Announces Conference Call and Webcast for 2026 First Quarter Financial Results
|
link
|
(GlobeNewswire)
|
|
Apr-15-26 08:45AM
|
PDS Biotech Announces Publication of Positive PDS01ADC Interim Phase 2 Clinical Trial Data from Stage 1 of NCI-led Metastatic Colorectal Cancer (mCRC) Trial
|
link
|
(GlobeNewswire)
|
|
Mar-31-26 08:30AM
|
PDS Biotechnology Corporation Q4 2025 Earnings Call Summary
|
link
|
(Moby)
|
|
Mar-30-26 09:01PM
|
PDS Biotechnology Corp (PDSB) Q4 2025 Earnings Call Highlights: Financial Discipline Amid ...
|
link
|
(GuruFocus.com)
|
|
Mar-30-26 07:10AM
|
PDS Biotechnology: Q4 Earnings Snapshot
|
link
|
(Associated Press)
|
|
Mar-30-26 07:00AM
|
PDS Biotech Reports Full Year 2025 Financial Results and Provides Update on PDS0101 Phase 3 Program and PDS01ADC Clinical Advancement
|
link
|
(GlobeNewswire)
|
|
Mar-24-26 04:05PM
|
PDS Biotech Announces Conference Call and Webcast for 2025 Fourth Quarter and Year End Financial Results
|
link
|
(GlobeNewswire)
|
|
Mar-11-26 04:59AM
|
Mutual Fund vs. ETF: Should You Buy VTSAX or VTI in 2026?
|
link
|
(TipRanks)
|
|
Feb-20-26 08:30AM
|
PDS Biotech Announces Adoption of Amended Protocol for Phase 3 VERSATILE-003 Trial Incorporating Progression Free Survival (PFS) as Primary Endpoint for Interim Analysis and Potential Accelerated Approval
|
link
|
(GlobeNewswire)
|
|
Jan-28-26 08:45AM
|
PDS Biotech Announces Presentation of Preliminary Results from Phase 2 Study of IL-12 Tumor Targeted Immunocytokine (PDS01ADC) in 3rd Line Metastatic Castration Resistant Prostate Cancer by the NCI
|
link
|
(GlobeNewswire)
|
|
Jan-22-26 08:45AM
|
PDS Biotech Announces New U.S. Patent Covering Technology Underlying PDS0101
|
link
|
(GlobeNewswire)
|
|
Jan-12-26 10:35AM
|
Fast-Tracking the $537B Cancer Cure: How Accelerated Approvals Reshaping Oncology in 2026
|
link
|
(PR Newswire)
|
|
Jan-09-26 08:45AM
|
PDS Biotech Announces FDA Alignment on use of Progression Free Survival (PFS) as Primary Endpoint
|
link
|
(GlobeNewswire)
|
|
Dec-09-25 08:00AM
|
PDS Biotech Announces New Composition of Matter Patent for PDS0101 in Japan
|
link
|
(GlobeNewswire)
|
|
Dec-08-25 12:00PM
|
PDS Biotechnology (PDSB) Upgraded to Buy: Here's Why
|
link
|
(Zacks)
|
|
Dec-02-25 08:30AM
|
PDS Biotech Announces Scheduling of Type C Meeting with U.S. Food and Drug Administration ("FDA")
|
link
|
(GlobeNewswire)
|
|
Nov-26-25 08:40AM
|
PDS Biotechnology price target lowered to $3 from $5 at B. Riley
|
link
|
(TipRanks)
|
|
Nov-13-25 02:06PM
|
PDS Biotechnology Corp (PDSB) Q3 2025 Earnings Call Highlights: Strategic Advances Amid ...
|
link
|
(GuruFocus.com)
|
|
Nov-13-25 07:40AM
|
PDS Biotechnology: Q3 Earnings Snapshot
|
link
|
(Associated Press Finance)
|
|
Nov-13-25 07:30AM
|
PDS Biotech Reports Third Quarter 2025 Financial Results and Provides Clinical Programs Update
|
link
|
(GlobeNewswire)
|
|
Nov-11-25 03:31PM
|
PDS Biotechnology Announces up to $11.1 Million Registered Direct Offering
|
link
|
(GlobeNewswire)
|
|
Nov-10-25 08:30AM
|
PDS Biotechnology Announces Translational Data Showing Strong Immunological and Clinical Activity of PDS0101 and PDS01ADC Presented at SITC 2025
|
link
|
(GlobeNewswire)
|
|
Nov-06-25 08:00AM
|
PDS Biotech Announces Conference Call and Webcast for Third Quarter 2025 Financial Results
|
link
|
(GlobeNewswire)
|
|
Oct-30-25 08:00AM
|
New Clinical and Translational Data on PDS Biotechnology's Novel Investigational Cancer Therapies PDS0101 and PDS01ADC to be Presented at the 2025 Society for Immunotherapy of Cancer (SITC) Annual Meeting
|
link
|
(GlobeNewswire)
|
|
Oct-29-25 08:37AM
|
PDS Biotech to Seek Expedited Approval Pathway for PDS0101 in HPV16-Positive Head and Neck Cancer
|
link
|
(GlobeNewswire)
|
|
Sep-18-25 08:45AM
|
PDS Biotech Sets Significant Benchmark in Head and Neck Cancer by Achieving Extended Survival in Low PD-L1 Expression (CPS 1-19) Cohort in VERSATILE-002 Trial, Potentially Eliminating Need for Chemotherapy in the Population
|
link
|
(GlobeNewswire)
|
|
Sep-02-25 08:00AM
|
PDS Biotech to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
|
link
|
(GlobeNewswire)
|
|
Aug-25-25 08:30AM
|
PDS Biotech Announces Final Topline Survival Data from VERSATILE-002 Phase 2 Trial in Head and Neck Cancer
|
link
|
(GlobeNewswire)
|
|
Aug-14-25 12:30PM
|
Biotech Stocks Rally as Oncology Market Targets $866B by 2034
|
link
|
(PR Newswire)
|
|
Aug-13-25 07:19AM
|
PDS Biotechnology: Q2 Earnings Snapshot
|
link
|
(Associated Press Finance)
|
|
Aug-13-25 07:00AM
|
PDS Biotech Reports Second Quarter 2025 Financial Results and Provides Clinical Programs Update
|
link
|
(GlobeNewswire)
|
|
Aug-06-25 08:00AM
|
PDS Biotech Announces Conference Call and Webcast for Second Quarter 2025 Financial Results
|
link
|
(GlobeNewswire)
|
|
Jul-11-25 07:16AM
|
PDS Biotechnology completes recruitment for stage one of colorectal cancer trial
|
link
|
(Clinical Trials Arena)
|
|
Jul-10-25 08:00AM
|
PDS Biotech Announces Colorectal Cancer Cohort of Phase 2 Clinical Trial with PDS01ADC Met Criteria for Expansion to Stage 2 Following Positive Stage 1 Results
|
link
|
(GlobeNewswire)
|
|
Jun-09-25 08:00AM
|
PDS Biotech to Host Key Opinion Leader Event to Discuss Versamune HPV for the Treatment of HPV16+ HNSCC
|
link
|
(GlobeNewswire)
|
|
Jun-02-25 10:01AM
|
Take the Zacks Approach to Beat the Markets: StoneCo, Axon, Intuit in Focus
|
link
|
(Zacks)
|
|
Jun-02-25 08:00AM
|
PDS Biotech Unveils Updated Positive Data From VERSATILE-002 Trial and Additional Trials Evaluating Versamune HPV to Treat Head and Neck Cancers at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
|
link
|
(GlobeNewswire)
|
|
May-23-25 10:55AM
|
PDS Biotechnology Corporation (PDSB)'s Versamune HPV Surpasses Survival Benchmarks in Recurrent Head and Neck Cancer Trial
|
link
|
(Insider Monkey)
|
|
May-22-25 05:26PM
|
PDS Biotech Announces Positive Extended Follow-Up Data for VERSATILE-002 and Additional Trials Evaluating Versamune HPV to be Presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
|
link
|
(GlobeNewswire)
|
|
May-20-25 08:00AM
|
PDS Biotech to Participate at the A.G.P. Virtual Annual Healthcare Company Showcase
|
link
|
(GlobeNewswire)
|
|
May-15-25 03:09AM
|
PDS Biotechnology Corp (PDSB) Q1 2025 Earnings Call Highlights: Strategic Advances Amid ...
|
link
|
(GuruFocus.com)
|
|
May-15-25 01:47AM
|
Q1 2025 PDS Biotechnology Corp Earnings Call
|
link
|
(Thomson Reuters StreetEvents)
|
|
May-14-25 07:38AM
|
PDS Biotechnology: Q1 Earnings Snapshot
|
link
|
(Associated Press Finance)
|
|
May-14-25 07:30AM
|
PDS Biotech Reports First Quarter 2025 Financial Results and Provides Clinical Programs and Corporate Update
|
link
|
(GlobeNewswire)
|
|
May-09-25 04:05PM
|
PDS Biotechnology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
|
link
|
(GlobeNewswire)
|
|
May-08-25 08:00AM
|
PDS Biotech Announces Additional Details on Two Preclinical Universal Influenza Presentations at IMMUNOLOGY2025 Annual Meeting
|
link
|
(GlobeNewswire)
|
|
May-07-25 08:00AM
|
PDS Biotech Announces Conference Call and Webcast for First Quarter 2025 Financial Results
|
link
|
(GlobeNewswire)
|
|
Apr-23-25 10:16AM
|
PDS Biotech Announces Multiple Abstracts Selected for Presentation at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
|
link
|
(GlobeNewswire)
|
|
Apr-16-25 08:00AM
|
PDS Biotech Announces Preclinical Influenza Data to be Presented in Symposium at IMMUNOLOGY2025 Annual Meeting
|
link
|
(GlobeNewswire)
|
|
Apr-08-25 08:00AM
|
PDS Biotech Announces PDS01ADC Clinical Data to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2025
|
link
|
(GlobeNewswire)
|
|
Mar-28-25 03:01AM
|
PDS Biotechnology Corp (PDSB) Q4 2024 Earnings Call Highlights: Strategic Advances Amid ...
|
link
|
(GuruFocus.com)
|
|
Mar-28-25 12:32AM
|
Q4 2024 PDS Biotechnology Corp Earnings Call
|
link
|
(Thomson Reuters StreetEvents)
|
|
Mar-27-25 10:35AM
|
PDS Biotechnology Corporation (PDSB) Q4 2024 Earnings Call Transcript
|
link
|
(SeekingAlpha)
|
|
Mar-27-25 07:30AM
|
PDS Biotech Reports Full Year 2024 Financial Results and Provides Clinical Programs Update
|
link
|
(GlobeNewswire)
|
|
Mar-25-25 08:00AM
|
PDS Biotech Leadership to Present at 2025 CAGLA NeauxCancer Conference
|
link
|
(GlobeNewswire)
|
|
Mar-23-25 08:52AM
|
PDS Biotechnology (PDSB): Among the Penny Stocks With Huge Upside Potential According to Analysts
|
link
|
(InsiderMonkey)
|
|
Mar-18-25 08:00AM
|
PDS Biotech Announces Conference Call and Webcast for Full Year 2024 Financial Results
|
link
|
(GlobeNewswire)
|
|
Mar-14-25 08:35AM
|
Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing
|
link
|
(GlobeNewswire)
|
|
Mar-14-25 07:22AM
|
FDA clears PDS Biotechnology's Versamune MUC1 combo for mCRC
|
link
|
(Pharmaceutical Business Review)
|
|
Mar-13-25 08:00AM
|
PDS Biotech Announces FDA Clearance of IND Application for Combination of Versamune MUC1 and PDS01ADC to Treat Metastatic Colorectal Cancer
|
link
|
(GlobeNewswire)
|
|
Mar-12-25 01:12PM
|
Life Sciences Investor Forum Agenda Announced for March 13th
|
link
|
(GlobeNewswire)
|
|
Mar-11-25 08:00AM
|
PDS Biotech Leadership to Participate in March Conferences
|
link
|
(GlobeNewswire)
|
|
Mar-10-25 12:49PM
|
PDS Biotechnology commences trial for head and neck squamous cell carcinoma
|
link
|
(Clinical Trials Arena)
|
|
Mar-07-25 08:45AM
|
PDS Biotech Initiates VERSATILE-003 Phase 3 Clinical Trial Evaluating Versamune HPV in HPV16-Positive Head and Neck Cancer
|
link
|
(GlobeNewswire)
|
|
Feb-27-25 08:00AM
|
PDS Biotech Announces up to $22 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
|
link
|
(GlobeNewswire)
|
|
Feb-26-25 08:00AM
|
PDS Biotech Announces Positive Clinical Data Demonstrating Compelling Survival and Clinical Responses in Recurrent/Metastatic HPV-Associated Cancers Published in JAMA Oncology
|
link
|
(GlobeNewswire)
|
|
Feb-24-25 08:00AM
|
PDS Biotech Announces Circulating Tumor DNA Results for Versamune HPV in IMMUNOCERV Trial Published in Clinical Cancer Research
|
link
|
(GlobeNewswire)
|
|
Feb-20-25 08:00AM
|
PDS Biotech to Participate at B. Riley Securities Precision Oncology & Radiopharma Conference 2025
|
link
|
(GlobeNewswire)
|
|
Feb-05-25 08:00AM
|
PDS Biotech Reaffirms Guidance for First Quarter Initiation of VERSATILE-003 Phase 3 Clinical Trial in HPV16-Positive Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
|
link
|
(GlobeNewswire)
|
|
Dec-06-24 08:00AM
|
PDS Biotechnology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
|
link
|
(GlobeNewswire)
|
|
Dec-03-24 08:00AM
|
PDS Biotech to Host Key Opinion Leader Event on December 17 at 12 p.m. ET
|
link
|
(GlobeNewswire)
|
|
Nov-20-24 09:35AM
|
Down -35.74% in 4 Weeks, Here's Why PDS Biotechnology (PDSB) Looks Ripe for a Turnaround
|
link
|
(Zacks)
|
|
Nov-15-24 02:08AM
|
PDS Biotechnology Corp (PDSB) Q3 2024 Earnings Call Highlights: Navigating Financial Challenges ...
|
link
|
(GuruFocus.com)
|
|
Nov-14-24 08:07AM
|
PDS Biotechnology: Q3 Earnings Snapshot
|
link
|
(Associated Press Finance)
|
|
Nov-14-24 08:00AM
|
PDS Biotech Provides Clinical Programs Update and Reports Third Quarter 2024 Financial Results
|
link
|
(GlobeNewswire)
|
|
Nov-06-24 08:00AM
|
PDS Biotech to Announce Third Quarter Financial Results on November 14, 2024 at 8:30 a.m. Eastern Time
|
link
|
(GlobeNewswire)
|
|
Oct-22-24 12:00PM
|
PDS Biotechnology (PDSB) Upgraded to Strong Buy: Here's What You Should Know
|
link
|
(Zacks)
|
|
Oct-22-24 08:00AM
|
PDS Biotech Announces Presentation of Rationale and Design of First Recurrent Prostate Cancer Trial to Combine an Androgen Receptor Pathway Inhibitor with an Immunocytokine
|
link
|
(GlobeNewswire)
|
|
Oct-02-24 08:00AM
|
PDS Biotech Announces 36-Month Overall Survival Rate of 84.4% in Locally Advanced Cervical Cancer Patients Treated with Versamune HPV and Chemoradiation
|
link
|
(GlobeNewswire)
|
|
Sep-16-24 07:00AM
|
PDS Biotech Announces Updated Results from VERSATILE-002 Phase 2 Clinical Trial Presented at ESMO 2024
|
link
|
(GlobeNewswire)
|
|
Sep-09-24 08:00AM
|
PDS Biotech to Present Updated VERSATILE-002 Data at ESMO Congress 2024
|
link
|
(GlobeNewswire)
|
|
Sep-03-24 08:00AM
|
PDS Biotech to Present at H.C. Wainwright 26th Annual Global Investment Conference
|
link
|
(GlobeNewswire)
|
|
Aug-13-24 08:09AM
|
PDS Biotechnology: Q2 Earnings Snapshot
|
link
|
(Associated Press Finance)
|
|
Aug-13-24 08:00AM
|
PDS Biotech Provides Business Update and Reports Second Quarter 2024 Financial Results
|
link
|
(GlobeNewswire)
|
|
Aug-08-24 08:00AM
|
PDS Biotech Announces Abstract Accepted for Oral Presentation at 2024 ASTRO Annual Meeting
|
link
|
(GlobeNewswire)
|
|
Aug-07-24 08:00AM
|
PDS Biotech to Announce Second Quarter Financial Results on August 13, 2024
|
link
|
(GlobeNewswire)
|
|
Aug-05-24 08:00AM
|
PDS Biotech Announces Abstract Accepted for Presentation at ESMO Congress 2024
|
link
|
(GlobeNewswire)
|
|
Aug-01-24 07:45AM
|
PDS Biotech Aligns with FDA on Phase 3 Trial in HPV16-Positive First-Line Recurrent or Metastatic Head and Neck Cancer
|
link
|
(GlobeNewswire)
|
|
Jul-31-24 04:01PM
|
PDS Biotech to Host Clinical Program Update Conference Call on August 1, 2024, at 8 a.m. Eastern Time
|
link
|
(GlobeNewswire)
|
|
Jul-29-24 08:00AM
|
PDS Biotech to Participate at BTIG Virtual Biotechnology Conference
|
link
|
(GlobeNewswire)
|
|
Jun-12-24 08:00AM
|
PDS Biotech Provides Data Update from Ongoing VERSATILE-002 Phase 2 Clinical Trial in Head and Neck Cancer
|
link
|
(GlobeNewswire)
|
|
May-28-24 01:24PM
|
Biotech Sector Working to Combat Rising Cases of Colorectal Cancer in Young Adults
|
link
|
(PR Newswire)
|
|
May-15-24 12:52PM
|
PDSB Stock Earnings: PDS Biotechnology Beats EPS for Q1 2024
|
link
|
(InvestorPlace)
|
ED-Finanzas